NCT05892471 (seccsa) is a NA clinical trial of ciprofol injection in Anesthesia, sponsored by Le Yu.

Who is sponsoring NCT05892471?

NCT05892471 is sponsored by Le Yu.

What drugs are being tested in NCT05892471?

Interventions in NCT05892471: ciprofol injection, Propofol injection.

What condition does NCT05892471 study?

NCT05892471 studies Anesthesia.

Is NCT05892471 still recruiting?

NCT05892471 is currently status unknown. Last updated 7 June 2023.

Last reviewed 2023-06-07 · How we verify

NCT05892471: seccsa

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety and Effectiveness of Ciprofol in Cardiac Surgery Anesthesia

Status unknown NA Last updated 7 June 2023

What this trial tests

NA trial testing ciprofol injection in Anesthesia in 80 participants. Status unknown.

Timeline

1 August 2022

Primary endpoint
1 August 2023

1 September 2023

Quick facts

Lead sponsor	Le Yu
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	other
Enrollment	80
Start date	1 August 2022
Primary completion	1 August 2023
Estimated completion	1 September 2023
Sites	1 location across China

Drugs / interventions tested

ciprofol injection
Propofol injection — full drug profile →

Conditions studied

Anesthesia — all drugs for Anesthesia →

Sponsor

Le Yu — full company profile →

Who can join

Adults 55 to 75, any sex, with Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ciprofol, a novel intravenous general anesthetic with a chemical structure akin to propofol, boasts significantly enhanced potency. It offers a rapid onset, reduced incidence of injection pain, and minor impact on the cardiovascular system. However, clinical research regarding ciprofol's use for anesthesia induction in cardiac surgery remains limited. The investigators want to assesse the safety and effectiveness of ciprofol in cardiac surgery anesthesia

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Anesthesia

Currently open trials in the same condition.

NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
NCT07465185 — Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery · Phase 2 · recruiting
NCT07269808 — Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration · Phase 3 · recruiting
NCT07443254 — Prospective IR-led Sedation Feasibility · Phase 1, PHASE2 · recruiting

Other Le Yu trials

Trials by the same sponsor.

NCT06469073 — Ultrasound-guided Modified Transversus Thoracic Muscle Plane Block and Erector Spinal Muscle Plane Block in Heart Valve · NA · recruiting
NCT06312345 — Ciprofol Versus Propofol for Anesthesia Induction in Cardiac Surgery: A Randomized Double-blind Controlled Clinical Tria · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05892471 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Le Yu
Last refreshed: 7 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05892471.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing